Amlodipine Besylate Tablet
Product Images NDC 60760-445
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 60760-445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)
Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)
This is a table of clinical trial results comparing the effectiveness of Amlodipine versus a placebo in treating patients with baseline sitting SBP (systolic blood pressure) greater or less than the mean value. The trial involved a total of 1318 participants, including subgroups of patients aged under 65 or 65 and over, male or female, and patients with different numbers of vessels with stenosis or previous PCI (procedural cardiac intervention) with or without stent placement. The table displays hazard ratios with 95% confidence intervals.*
Logo (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 04)
Logo (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 05)
Am (Amlodipine 60760 445 30)
This is the description: NDC 60760-445-30 is a medication containing Amiodipine Besylate available in tablet form. The tablets come in 10mg strength with each pack containing 30 tablets. The details of the manufacturer, Unichem Laboratories, are also mentioned. The medication is to be used as directed and stored within controlled temperature limits.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.